Related references
Note: Only part of the references are listed.Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
Carla Damaschin et al.
LEUKEMIA (2022)
Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures
J. Bodden et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp
Anna Santarsieri et al.
BLOOD (2021)
Male and Female Fertility: Prevention and Monitoring Hodgkin' Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi
Simonetta Viviani et al.
CANCERS (2021)
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
Joachim Baech et al.
LEUKEMIA & LYMPHOMA (2020)
Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments
Charles L. Shapiro
CANCERS (2020)
PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study
Olivier Casasnovas et al.
BLOOD (2020)
Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)
Sven Borchmann et al.
LEUKEMIA (2019)
OPPORTUNISTIC EVALUATION OF BONE MINERAL DENSITY BY PET-CT IN HODGKIN LYMPHOMA PATIENTS
Bar Cohen et al.
ENDOCRINE PRACTICE (2019)
Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious
Anna Santarsieri et al.
BLOOD (2019)
Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis
Takamichi Yokoe et al.
ONCOLOGIST (2019)
ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
Yasmeen Razvi et al.
SUPPORTIVE CARE IN CANCER (2019)
Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study
Konstantinos Anargyrou et al.
HEMASPHERE (2019)
Bone loss and hematological malignancies in adults: a pilot study
Rosa Ruchlemer et al.
SUPPORTIVE CARE IN CANCER (2018)
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients
Pernille Svendsen et al.
LEUKEMIA & LYMPHOMA (2017)
Opportunistic Use of CT Imaging for Osteoporosis Screening and Bone Density Assessment A Qualitative Systematic Review
Elizabeth B. Gausden et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2017)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Paul J. Hesketh et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
NCCN Guidelines® Insights Antiemesis, Version 2.2017 Featured Updates to the NCCN Guidelines
Michael J. Berger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann et al.
LANCET (2017)
A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)
Michio Nakamura et al.
ONCOLOGIST (2017)
NCCN Task Force Report: Bone Health in Cancer Care
Julie R. Gralow et al.
Journal of the National Comprehensive Cancer Network (2017)
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients
Eldad J. Dann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening
P. J. Pickhardt et al.
OSTEOPOROSIS INTERNATIONAL (2016)
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816
Oliver W. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Use of routine thoracic and abdominal computed tomography scans for assessing bone mineral density and detecting osteoporosis
Milka Marinova et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Michael Schaapveld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prevention and treatment of bone fragility in cancer patient
Silva Ottanelli
CLINICAL CASES IN MINERAL AND BONE METABOLISM (2015)
Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study
J. Paccou et al.
ANNALS OF ONCOLOGY (2014)
Opportunistic Screening for Osteoporosis Using Abdominal Computed Tomography Scans Obtained for Other Indications
Perry J. Pickhardt et al.
ANNALS OF INTERNAL MEDICINE (2013)
Correlation between Bone Mineral Density Measured by Dual-Energy X-Ray Absorptiometry and Hounsfield Units Measured by Diagnostic CT in Lumbar Spine
Sungjoon Lee et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2013)
Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Robert S. Weinstein
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Andreas Engert et al.
LANCET (2012)
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma
Andrea K. Ng
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Management of fertility in patients treated for Hodgkin's lymphoma
Stephanie Harel et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
Simonetta Viviani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006
Hans H. Storm et al.
ACTA ONCOLOGICA (2010)
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
C. E. Kiserud et al.
BRITISH JOURNAL OF CANCER (2009)
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NCCN Task Force Report: Bone Health in Cancer Care
Julie R. Gralow et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Survival Expectations of Patients Diagnosed with Hodgkin's Lymphoma in 2006-2010
Hermann Brenner et al.
ONCOLOGIST (2009)
Long-term cause-specific mortality of patients treated for Hodgkin's disease
BMP Aleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis
TP van Staa et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
TP van Staa et al.
RHEUMATOLOGY (2000)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
